Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.748 SEK | -0.90% | -2.78% | -3.60% |
Sales 2023 | 9M 841K | Sales 2024 * | 26.75M 2.5M | Capitalization | 308M 28.75M |
---|---|---|---|---|---|
Net income 2023 | -89M -8.31M | Net income 2024 * | -96M -8.97M | EV / Sales 2023 | -1.16 x |
Net cash position 2023 | 170M 15.84M | Net cash position 2024 * | 94.7M 8.85M | EV / Sales 2024 * | 7.97 x |
P/E ratio 2023 |
-1.93
x | P/E ratio 2024 * |
-3.04
x | Employees | 10 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.19% |
Latest transcript on Medivir AB
1 day | -0.90% | ||
1 week | -2.78% | ||
Current month | -11.64% | ||
1 month | -14.94% | ||
3 months | -3.26% | ||
6 months | -61.28% | ||
Current year | -3.60% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.748 | -0.90% | 843,740 |
24-03-27 | 2.772 | -2.33% | 144,328 |
24-03-26 | 2.838 | +3.37% | 507,195 |
24-03-25 | 2.746 | +0.59% | 87,131 |
24-03-22 | 2.73 | -3.40% | 106,199 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.60% | 28.81M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |